Chimerix Stock Forum

$Chimerix (CMRX.US)$
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
Chimerix (NASDAQ: CMRX) announced updated Phase 2 response assessment results for dordaviprone in treating recurrent H3 K27M-mutant diffuse midline glioma. Using the new RANO 2.0 criteria, the treatment showed a 28.0% overall response rate, with a median time to response of 4.6 months and a median duration of response of 10.4 months. The company plans...

$Chimerix (CMRX.US)$ …why high peak?

Tonix initiates Phase II trial for emergency cocaine intoxication treatment
$Tonix Pharmaceuticals (TNXP.US)$

$Chimerix (CMRX.US)$ .. supposed be rise…but drop !!!!

$Virax Biolabs (VRAX.US)$ $Airship AI (AISP.US)$ $Personalis (PSNL.US)$ $Emergent BioSolutions (EBS.US)$ $Chimerix (CMRX.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

$Chimerix (CMRX.US)$ ONC206 is a second generation ClpP agonist and DRD2 antagonist that has demonstrated monotherapy anti-cancer activity in pre-clinical models in primary CNS tumors and solid tumors outside of the CNS.
Phase I dose escalation trials continue at the National Institutes of Health (NIH) and the Pacific Pediatric Neuro-Oncology Consortium (PNOC) in adult and pediatric CNS tumor patients, respectively. The dose escalation trials are currently dosing at a...

$Chimerix (CMRX.US)$ Strong Buy Rating for Chimerix on Robust Financials and Promising Drug Pipeline